Epstein-Barr virus vaccine research

8 November 2011

An article in this month’s journal, Science Translational Medicine, says future Epstein-Barr virus (EBV) vaccine research should aim to identify disease-predictive biomarkers.

[Although the article is of primary interest to cancer researchers, prompting coverage by the US Institute of Cancer, the story is noted here because glandular fever or Epstein-Barr virus (EBV) can also trigger M.E.]